I-MED Pharma, Inc., a Canadian company specializing in dry eye diagnosis and management is proud to announce a strategic collaboration with Keir Surgical Ltd. to service the ophthalmic needs of Canadian hospitals and Canadian ophthalmologists. As of February 1st, 2021, Keir Surgical will take ownership of I-MED Pharma’s surgical portfolio.
Daniel Hofmann, President of I-MED Pharma stated, “We are proud to have found a great partner in Keir Surgical to pass on our surgical legacy to. It is extremely important to us that our loyal surgical clientele is well supported moving forward, and we are convinced that Keir Surgical will do an excellent job in providing best in class service to these customers.”
I-MED Pharma will continue to focus efforts on their dry eye product portfolio and will reinvest the proceeds of this transaction into further strengthening their leadership position as one of the top global providers of OSD solutions.
Patrick Haney, President of Keir Surgical commented, “We are excited to be adding such a comprehensive and successful ophthalmic product portfolio to our existing surgical offering and we are eager to continue to support the Canadian clients who rely on these great products.”
About Keir Surgical Ltd.
Keir Surgical Ltd. is a Canadian owned and operated surgical products company dedicated to providing its customers with quality products and service. Keir Surgical has provided high-quality surgical products to hospitals, clinics, and healthcare facilities across Canada for more than 95 years.
To learn more about Keir Surgical, visit keirsurgical.com.
About I-MED Pharma
I-MED Pharma Inc. is a privately held Canadian company, headquartered in Montreal, Quebec. As a research-based firm with the vision to be the most important dry eye and ocular surface disease company in the world, I-MED Pharma provides innovative OSD solutions to the global optometry and ophthalmology community. Through the years, I-MED Pharma has continuously invested heavily in R&D and has created unique and effective products for the management of dry eye disease. A pioneer in the field of artificial tears and ocular hygiene cleansers, I-MED Pharma’s signature product lines include I-DROP® and I-LID ’N LASH®, which are sold around the world.
I-MED Pharma offers a complete range of ocular surface disorder products, including diagnostic tools, artificial tears, dry eye ointment, ocular hygiene cleansers, punctum plugs, nutritional supplements, therapeutic accessories, as well as the E-Eye IRPL®, a long-lasting solution designed specifically for the treatment of dry eyes due to Meibomian Gland Dysfunction.
For more information, please email email@example.com or visit www.imedpharma.com.